Stryker Corp. buy Royal Bank of Canada
Start price
11.12.24
/
50%
€362.30
Target price
11.12.25
€404.73
Performance (%)
-17.03%
End price
12.12.25
€300.60
Summary
This prediction ended on 12.12.25 with a price of €300.60. The price of Stryker Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.03%. Royal_Bank_of_Canada has a follow-up prediction for Stryker Corp. where he still thinks Stryker Corp. is a Buy. Dividends of €1.66 are taken into consideration when calculating the performance. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Stryker Corp. | 13.542% | 13.542% | -11.275% |
| iShares Core DAX® | 1.014% | 2.699% | 4.363% |
| iShares Nasdaq 100 | -6.470% | -8.771% | 18.004% |
| iShares Nikkei 225® | -6.517% | -12.580% | 40.915% |
| iShares S&P 500 | -2.721% | -1.752% | 16.966% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Stryker Corp. diskutieren
Stryker Co. (NYSE: SYK) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $425.00 price target on the stock, up previously from $400.00.
Ratings data for SYK provided by MarketBeat
In the thread Trading Stryker Corp.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten